Andrea Wecker

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.

Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.

Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.

Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.

Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization.

Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.

Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI.

Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Derivation and characterization of bone marrow-derived multipotent stem cells.

Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.

Bone marrow-derived stem cell therapy in ischemic heart disease.

Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart.

Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.

Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.

CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.